Efficacy of ustekinumab for ulcerative colitis through 2 years: Results of the UNIFI maintenance study and long-term extension

被引：0

作者：

Panaccione, R. ^{[1
]}

Sandborn, W. J. ^{[2
]}

Sands, B. E. ^{[3
]}

Marano, C. ^{[4
]}

O'Brien, C. D. ^{[4
]}

Zhang, H. ^{[5
]}

Johanns, J. ^{[5
]}

Zhou, Y. ^{[5
]}

Peyrin-Biroulet, L. ^{[6
]}

Hisamatsu, T. ^{[7
]}

Danese, S. ^{[8
]}

机构：

[1] Univ Calgary, Ctr Inflammatory Bowel Dis, Calgary, AB, Canada

[2] Univ Calif San Diego, Gastroenterol, La Jolla, CA 92093 USA

[3] Icahn Sch Med Mt Sinai, Gastroenterol, New York, NY 10029 USA

[4] Janssen Res & Dev LLC, Immunol, Spring House, PA USA

[5] Janssen Res & Dev LLC, Clin Biostats, Spring House, PA USA

[6] Nancy Univ Hosp, Gastroenterol, Nancy, France

[7] Kyorin Univ, Internal Med, Tokyo, Japan

[8] Humanitas Res Hosp, Gastroenterol, Milan, Italy

来源：

JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

DOP12

引用

页码：S049 / S049

页数：1

共 50 条

[31] USTEKINUMAB MAINTAINED CLINICALLY MEANINGFUL IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS FROM THE UNIFI LONG-TERM EXTENSION
Sandborn, William J.
Rowbotham, David
Leong, Rupert W.
Han, Chenglong
Zhou, Yiying
Zhang, Hongyan
Johanns, Jewel
Marano, Colleen W.
Danese, Silvio
GASTROENTEROLOGY, 2020, 158 (06) : S433 - S433
[32] Ustekinumab maintained clinically meaningful improvement in health-related quality of life in patients with moderate to severe ulcerative colitis: Results from the UNIFI long-term extension
Sandborn, W. J.
Rowbotham, D. S.
Leong, R. W. L.
Han, C.
Zhou, Y.
Zhang, H.
Johanns, J.
Marano, C.
Danese, S.
JOURNAL OF CROHNS & COLITIS, 2020, 14 : S094 - S095
[33] EFFICACY AND SAFETY OF USTEKINUMAB THROUGH WEEK 16 IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS RANDOMIZED TO USTEKINUMAB: RESULTS FROM THE UNIFI INDUCTION TRIAL
Danese, Silvio
Sands, Bruce E.
O'Brien, Christopher D.
Zhang, Hongyan
Johanns, Jewel
Sloan, Sheldon
Izanec, James L.
Szapary, Philippe
Marano, Colleen W.
Leong, Rupert W.
Rowbotham, David
Targan, Stephan R.
Van Assche, Gert A.
GASTROENTEROLOGY, 2019, 156 (06) : S1106 - S1106
[34] Long-term efficacy of ustekinumab with and without concomitant immunosuppressants for Crohn's disease: results from IM-UNITI long-term extension through 2 years
Ghosh, S.
Kramer, B. C.
Gasink, C.
Jacobstein, D.
Adedokun, O. J.
Gao, L. -L.
Rutgeerts, P.
Sands, B. E.
JOURNAL OF CROHNS & COLITIS, 2019, 13 : S459 - S460
[35] LONG-TERM EFFICACY AND SAFETY OF USTEKINUMAB FOR CROHN'S DISEASE: RESULTS FROM IM-UNITI LONG-TERM EXTENSION THROUGH TWO YEARS
Sandborn, William J.
Rutgeerts, Paul
Gasink, Christopher
Jacobstein, Douglas
Gao, Long-Long
Johanns, Jewel
Sands, Bruce E.
Hanauer, Stephen B.
Targan, Stephan R.
Ghosh, Subrata
de Villiers, Willem J.
Colombel, Jean Frederic
Feagan, Brian G.
GASTROENTEROLOGY, 2017, 152 (05) : S585 - S585
[36] Long-term outcomes after histological and endoscopic mucosal healing: Results from the UNIFI study in ulcerative colitis
Leong, R.
Sands, B. E.
Peyrin-Biroulet, L.
Marano, C.
Miao, Y.
Izanec, J.
Feagan, B. G.
Rubin, D. T.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 129 - 130
[37] Long-Term Efficacy of Ustekinumab With and Without Concomitant Immunosuppressants for Crohn's Disease: Results From IM-UNITI Long-Term Extension Through 2 Years
Sands, Bruce E.
Kramer, Brian
Gasink, Christopher
Jacobstein, Douglas
Adedokun, Omoniyi J.
Gao, Long-Long
Rutgeerts, Paul
Ghosh, Subrata
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S329 - S329
[38] Efficacy and safety of ustekinumab through Week 16 in patients with moderate-to-severe ulcerative colitis randomised to ustekinumab: results from the UNIFI induction trial
Danese, S.
Sands, B. E.
O'Brien, C. D.
Zhang, H.
Johanns, J.
Sloan, S.
Izanec, J.
Szapary, P.
Marano, C.
Leong, R. W.
Rowbotham, D.
Targan, S. R.
Van Assche, G.
JOURNAL OF CROHNS & COLITIS, 2019, 13 : S61 - S62
[39] Efficacy and safety of ustekinumab through Week 16 in patients with moderate to severe ulcerative colitis: Results from the UNIFI induction trial
Danese, S.
Sands, B.
O'Brien, C.
Zhang, H.
Johanns, J.
Sloan, S.
Izanek, J.
Szapary, P.
Marano, C.
Leong, R.
Rowbotham, D.
Targan, S.
Van Assche, G.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 130 - 131
[40] Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study
Chaparro, Maria
Hermida, Sandra
Acosta, Diana
Fernandez-Clotet, Agnes
Barreiro-de Acosta, Manuel
Hernandez Martinez, Alvaro
Arroyo, Maite
Bosca-Watts, Marta Maia
Diz-Lois Palomares, M. Teresa
Menchen, Luis
Martinez Cadilla, Jesus
Leo-Carnerero, Eduardo
Munoz Villafranca, Carmen
Sierra-Ausin, Monica
Gonzalez-Lama, Yago
Riestra, Sabino
Sendra Rumbeu, Pau
Cabello Tapia, M. Jose
Garcia de la Filia, Irene
Vicente, Raquel
Ceballos, Daniel
Pajares Villarroya, Ramon
Ramirez de la Piscina, Patricia
Martin-Arranz, Maria Dolores
Ramos, Laura
Ruiz-Cerulla, Alexandra
Martinez-Perez, Teresa de Jesus
San Miguel Amelivia, Elena
Calvet, Xavier
Huguet, Jose Maria
Keco-Huerga, Alma
Lorente Poyatos, Rufo H.
Munoz, Jose Fernando
Ponferrada-Diaz, Angel
Sicilia, Beatriz
Delgado-Guillena, Pedro
Gomez Delgado, Elena
Rancel-Medina, Francisco J.
Alonso-Galan, Horacio
Herreros, Belen
Rivero, Montserrat
Varela, Pilar
Bermejo, Fernando
Garcia Sepulcre, Marife
Gimeno-Pitarch, Leticia
Kolle-Casso, Lilyan
Marquez-Mosquera, Lucia
Martinez Tirado, Pilar
Ramirez, Cynthia
Sese Abizanda, Eva
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (10) : 1325 - 1338

← 1 2 3 4 5 →